'김갑성' 기자의 전체기사
-
Kelun-Biotech to Present Results from Multiple Clinical Studie…
CHENGDU, China, Sept. 23, 2025 -- The 2025 European Society for Medical Oncology (ESMO) Congress will take place in Berlin, Germany, from October 17 to 21. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990) will present results from multiple clinical studies at the congress, including data from its TROP2 ADC sacituzumab tirumotecan (sac-TMT), HER2 ADC A166 (trastuzumab botidotin), and CLDN18.2 ADC SKB315. Among these, two Phase III clinical studies of sac-TMT were selected for the Latest Breakthrough Abstracts (LBA) and presented as oral reports,
- 김갑성 기자
- 2025-09-23 17:03
-
Economist Impact's 5th edition Future of Health Asia returns to…
Singapore to host 500 health, science and policy leaders on October 16th to address pressing issues in the Asia-Pacific healthcare sector. Members of the media are invited to register here. SINGAPORE, Sept. 23, 2025 -- Convening on October 16th at the Four Seasons Hotel, the 5th edition Future of Health Asia will bring together 500 senior leaders from healthcare, government and patient advocacy to examine the impact of rising technological disruptions, rising pressure of chronic diseases and global economic uncertainty. The Asia-Pacific's healthcare secto
- 김갑성 기자
- 2025-09-23 14:50
-
Mindray Unveils Project 2030 and Re-writes the Future of Women…
CANCUN, Mexico, Sept. 23, 2025 -- On September 15th, at ISUOG 2025 World Congress in Cancun, Mexico, Mindray unveiled Project 2030, an initiative to improve global access to ultrasound technology. The project was launched to an international audience of leading specialists, capping a conference that featured Mindray's OBG solutions as a key highlight. Mindray's Women Healthcare Ultrasound Solution Shines on the Stage During the congress, Prof. Savino Gil Pugliese (Head of Fetal Surgery, University Hospital of Córdoba) and Prof. Roberto Albinagorta (ISUOG Ambassado
- 김갑성 기자
- 2025-09-23 13:48
-
WuXi Biologics Selected as Constituent of FTSE4Good Index S…
SHANGHAI, Sept. 23, 2025 -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been selected as a constituent company of the FTSE4Good Index Series, marking the fifth consecutive year the company has been recognized by FTSE Russell for outstanding sustainability performance. The FTSE4Good Index Series, launched in 2001 by FTSE Russell (now part of the London Stock Exchange Group), is a family of equity indices designed to measure the performance of companies demonstrating strong Environmental, Social
- 김갑성 기자
- 2025-09-23 12:00
-
Kelun-Biotech's New Drug Application for Its Novel Next-gene…
CHENGDU, China, Sept. 23, 2025 -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that a new drug application (NDA) for the Company's small molecule rearranged during transfection (RET) kinase inhibitor A400 (also known as EP0031) was accepted for review by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China for the treatment of adult patients with RET-fusion positive locally advanced, or metastatic non-small cell lung cancer (NSCLC). This acceptance for review is based on the positive results from
- 김갑성 기자
- 2025-09-23 10:22
-
Xinjiang celebrates seven decades of progress
BEIJING, Sept. 23, 2025 -- This is a report from Beijing Review: A quiet revolution is underway in the vast cotton fields of Bortala Mongolian Autonomous Prefecture in north Xinjiang where harvesting machines, guided by digital sensors, operate with minimal human intervention. According to Aoqierbate, head of the prefecture's Bureau of Agriculture and Rural Affairs, now hundreds of hectares of cotton can be harvested by just one or two machine operators. Dilinur comes from a farming family in Bortala. In the past, the family's livelihood depended entirely on the weather. Farmin
- 김갑성 기자
- 2025-09-23 10:10
-
ObesityConnects, an Obesity-Fighting Platform to Connect Pa…
The Chulalongkorn Bariatric and Metabolic Institute (Chula BMI) launched ObesityConnects, a Line Official platform to connect obese patients to continuous treatment from specialists, while offering preventative information and daily health check-up features for the public who wish to stave off obesity. BANGKOK, Sept. 23, 2025 -- Obesity is a health problem threatening the quality of life of Thai people. Data from the Chula BMI reveals alarming statistics that currently, among every 3 people in Thailand, 1 person has obesity! This trend appears to be increasing every year.
- 김갑성 기자
- 2025-09-23 10:00
-
GC Biopharma Submits IND Application for Phase 1 Clinical Trial…
YONGIN, South Korea, Sept. 23, 2025 -- GC Biopharma (006280.KS), a leading South Korean pharmaceutical company, announced today that it has submitted an Investigational New Drug (IND) application to the Ministry of Food and Drug Safety (MFDS) in South Korea for a Phase 1 clinical trial of "GC4006A," its mRNA (messenger RNA) vaccine candidate for COVID-19. The development of GC4006A has progressed rapidly since April 2025, when the Korea Disease Control and Prevention Agency (KDCA) selected GC Biopharma to lead the agency's "the mRNA Vaccine Developm
- 김갑성 기자
- 2025-09-23 09:41
-
Angel Yeast's Breakthrough in Yeast Protein Research: Ang…
YICHANG, China, Sept. 23, 2025 -- Angel Yeast (SH600298), a leading global food ingredients and biotechnology company, today announced a major advancement in research on its yeast protein product AngeoPro. New scientific studies confirm that yeast protein provides a balanced amino acid profile—nearly 48% of which are essential amino acids—closely aligning with the ideal protein reference standard. Importantly, the findings highlight yeast protein's ability to enhance calcium absorption and its potential role in supporting long-term bone health. Research Highlights: Calc
- 김갑성 기자
- 2025-09-23 09:00
-
Korea's XR Startup DoubleMe To Reveal Breakthrough AI Tec…
[ 메디채널 김갑성 기자 ] DoubleMe, Korea's leading XR startup, to showcase its Next-Gen XR technologies to the Japanese wellness market in Tokyo this Fall. SEOUL, South Korea, Sept. 23, 2025 -- DoubleMe, a global pioneer in spatial computing and immersive technology, will visit the Autumn 2025 Tokyo XR Fair from October 8 - 10, 2025 to present their latest immersive technologies and share innovative mental health solutions with the Japanese market. DoubleMe plans to serve Japanese locals with XR-based healing experiences compatible with Japan's traditional Zen meditation cult
- 김갑성 기자
- 2025-09-23 09:00
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-19_SUN
- Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting 15:00
- Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia 14:00
- From Wellbeing to Academics: Why HK Parents Are Hitting Pause on Kids' Social Media and Device Use 13:00
- 내면의 조화를 발견하세요: '원더풀 인도네시아 웰니스 페스티벌 2025' 개최 01:50
- 제2회 마나르 아부다비 출품 작가 명단 공개 00:48
- 중국-피지 어업 협력, 섬나라 경제 활력 끌어올리다 00:00
2025-10-18_SAT
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 19일 16시 40분